These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2982955)

  • 1. Fixed herpes simplex type 1-infected cells as antigen for in vitro lymphocyte proliferation.
    Welling-Wester S; Huitema BA; Wilterdink JB
    J Immunol Methods; 1985 Feb; 76(2):239-46. PubMed ID: 2982955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro.
    Cunningham AL; Noble JR
    J Clin Invest; 1989 Feb; 83(2):490-6. PubMed ID: 2464000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors.
    Schmid DS; Rouse BT
    J Immunol; 1983 Jul; 131(1):479-84. PubMed ID: 6223080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immune response to herpes simplex virus: comparison of the specificity and relative titers of serum antibodies directed against viral polypeptides following primary herpes simplex virus type 1 infections.
    Eberle R; Mou SW; Zaia JA
    J Med Virol; 1985 Jun; 16(2):147-62. PubMed ID: 2409225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycoprotein gE of herpes simplex virus type 1: effects of anti-gE on virion infectivity and on virus-induced fc-binding receptors.
    Para MF; Baucke RB; Spear PG
    J Virol; 1982 Jan; 41(1):129-36. PubMed ID: 6283107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Native and recombinant herpes simplex virus type 1 envelope proteins induce human immune T-lymphocyte responses.
    Torseth JW; Cohen GH; Eisenberg RJ; Berman PW; Lasky LA; Cerini CP; Heilman CJ; Kerwar S; Merigan TC
    J Virol; 1987 May; 61(5):1532-9. PubMed ID: 3033279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diminished interferon-gamma and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection.
    Burchett SK; Corey L; Mohan KM; Westall J; Ashley R; Wilson CB
    J Infect Dis; 1992 May; 165(5):813-8. PubMed ID: 1314868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro stimulation of human lymphocytes by purified cytomegalovirus.
    Moller-Larsen A; Andersen HK; Heron I; Sarov I
    Intervirology; 1975-1976; 6(4-5):249-57. PubMed ID: 186434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte and IgG responses to different herpes simplex virus antigens in patients with frequent HSV-1 reactivations.
    Ljungman P; Zetterqvist L; Sundqvist VA; Jeansson S; Heimdahl A; Wahren B
    Clin Exp Immunol; 1988 May; 72(2):207-10. PubMed ID: 2842095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class II induction of human corneal fibroblasts by cell-free supernatants from HSV stimulated lymphocytes.
    Young E; Pepose JS
    Curr Eye Res; 1987 Jan; 6(1):141-4. PubMed ID: 3030637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD.
    Zarling JM; Moran PA; Burke RL; Pachl C; Berman PW; Lasky LA
    J Immunol; 1986 Jun; 136(12):4669-73. PubMed ID: 2423598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses to herpes simplex virus in patients with recurrent herpes labialis: I. Development of cell-mediated cytotoxic responses.
    Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Cohen E; Orsini F; Ogra PL
    Clin Exp Immunol; 1986 Dec; 66(3):507-15. PubMed ID: 2436840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of herpes simplex virus antigens on the surface of mouse cells of the H-2b haplotype by virus-specific cytotoxic T lymphocytes.
    Jennings SR; Rice PL; Pan S; Knowles BB; Tevethia SS
    J Immunol; 1984 Jan; 132(1):475-81. PubMed ID: 6197457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
    Ritchie MH; Oakes JE; Lausch RN
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes simplex virus-2 (HSV-2) type-specific antibody correlates of protection in infants exposed to HSV-2 at birth.
    Ashley RL; Dalessio J; Burchett S; Brown Z; Berry S; Mohan K; Corey L
    J Clin Invest; 1992 Aug; 90(2):511-4. PubMed ID: 1322941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 165 kd protein of the herpes simplex virion shares a common epitope with the regulatory protein, ICP4.
    Bibor-Hardy V; Sakr F
    Biochem Biophys Res Commun; 1989 Aug; 163(1):124-30. PubMed ID: 2476124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of herpes simplex virus-specific helper T lymphocyte precursors in the lymph node cells of infected mice.
    Prymowicz D; Moore RN; Rouse BT
    J Immunol; 1985 Apr; 134(4):2683-8. PubMed ID: 2579150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB.
    Kitamura K; Namazue J; Campo-Vera H; Ogino T; Yamanishi K
    Virology; 1986 Feb; 149(1):74-82. PubMed ID: 2418583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.